www.youtube.com/watch?v=prqr...
#video #videoedit #youtubechannel #youtube #photography #videos #photo #Toys #toyphotography #MyCollection #fotografia #foto #arte #coleccion #coleccionismo #Gameoverse #Kit #Animatez #Glitch
www.youtube.com/watch?v=PrqR...
www.youtube.com/watch?v=PrqR...
FPL General's 2m+ rank rise in #gw13 #fpl thanks to not owning the 🤖
www.youtube.com/watch?v=PRqr...
FPL General's 2m+ rank rise in #gw13 #fpl thanks to not owning the 🤖
www.youtube.com/watch?v=PRqr...
But, of course, Trump and the (drug dev) markets.
But, of course, Trump and the (drug dev) markets.
#genomics have been major market laggards, now leading #biotech rebound. The leaders of the new leadership sector. FOMO will follow. $verv $qure $prqr $sgmo
#genomics have been major market laggards, now leading #biotech rebound. The leaders of the new leadership sector. FOMO will follow. $verv $qure $prqr $sgmo
www.youtube.com/watch?v=PrqR...
www.youtube.com/watch?v=PrqR...
Key question: is this iteration potent enough for its specific use-case, or will it still need some tweaks?
$WVE $PRQR $KRRO
Key question: is this iteration potent enough for its specific use-case, or will it still need some tweaks?
$WVE $PRQR $KRRO
Landmark ATTR-Polyneuropathy Data by Intellia Caps Off Momentous Week in #CRISPR Therapeutics (blog): rnaitherapeutics.blogspot.com/2025/05/land...
#CPS1 #Musunuru $NTLA $PRME $VERV $BEAM $PRQR
Landmark ATTR-Polyneuropathy Data by Intellia Caps Off Momentous Week in #CRISPR Therapeutics (blog): rnaitherapeutics.blogspot.com/2025/05/land...
#CPS1 #Musunuru $NTLA $PRME $VERV $BEAM $PRQR
#StockMarket #News
#StockMarket #News
$PRQR $KRRO $BEAM
$PRQR $KRRO $BEAM
NTCP cholestatic disease candidate on track for Q2 CTA filing and Q4 readout (healthy volunteer, biomarker)
Cash runway into mid-2027.
finance.yahoo.com/news/proqr-a...
NTCP cholestatic disease candidate on track for Q2 CTA filing and Q4 readout (healthy volunteer, biomarker)
Cash runway into mid-2027.
finance.yahoo.com/news/proqr-a...
Overall moving more into CNS. Cash into H2 2027, $LLY still w/ opt-in rights for 5 additional targets.
www.proqr.com/press-releas...
Overall moving more into CNS. Cash into H2 2027, $LLY still w/ opt-in rights for 5 additional targets.
www.proqr.com/press-releas...
#$PRQR #Biotech #Axiomer #RNAEditing
#$PRQR #Biotech #Axiomer #RNAEditing
www.youtube.com/watch?v=PrqR...
www.youtube.com/watch?v=PrqR...
#news #investing #stocks
https://www.stocktitan.net/news/PRQR/pro-qr-therapeutics-announces-8-1-million-in-new-funding-from-rett-y7k961jw6tpv.html
#news #investing #stocks
https://www.stocktitan.net/news/PRQR/pro-qr-therapeutics-announces-8-1-million-in-new-funding-from-rett-y7k961jw6tpv.html
www.youtube.com/watch?v=PrqR...
www.youtube.com/watch?v=PrqR...
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/so...
$RANI $CELC $RARE $PRQR $IPA $EPIX $MGRM
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/so...
$RANI $CELC $RARE $PRQR $IPA $EPIX $MGRM
www.proqr.com/press-releas...
www.proqr.com/press-releas...